The value of the clinical endocrinologist in the new millennium

被引:0
作者
Levetan, CS [1 ]
机构
[1] Washington Hosp Ctr, Endocrinol Sect, MedStar Res Inst, Washington, DC 20003 USA
关键词
D O I
10.1097/00019616-200103000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In all aspects of today's society, specialization has been associated with increased productivity and enhanced outcomes. In the fields of science, technology, manufacturing, and production, specialization has resulted in improved efficiency accompanied by lower costs. It is ironic that in the field of medicine, as technological and medical advances are occurring so rapidly, the trend away from specialists and back toward generalist care is viewed as progressive and cost effective. As health care delivery changes in the United States, it will be critically important for patients, health plans, and purchasers of health care to recognize the value of endocrinologists. Endocrinologists are specialist physicians who are trained to prevent complications. Care by endocrinologists has resulted in significantly lower costs with improved outcomes, including lower morbidity and mortality rates, reduced hospital length of stay, fewer medical procedures, reduced hospital read mission, and more cost efficient and time saving medical evaluations (Tables I and 2). Similar findings have also been demonstrated when specialists care for patients with congestive heart failure, myocardial infarction, and asthma [1-8]. The cognitive talents and skills of special ists, which can prevent costly procedures, such as bypass surgery and amputations, must become as valued by our health care system as the technical skills of our medical colleagues, who are trained to perform surgical procedures on patients who were not fortunate enough to see an endocrinologist earlier in the course of their disease.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 44 条
  • [1] Alsever R N, 1995, Physician Exec, V21, P39
  • [2] KNOWLEDGE AND PRACTICES OF GENERALIST AND SPECIALIST PHYSICIANS REGARDING DRUG-THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    AYANIAN, JZ
    HAUPTMAN, PJ
    GUADAGNOLI, E
    ANTMAN, EM
    PASHOS, CL
    MCNEIL, BJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (17) : 1136 - 1142
  • [3] DIABET CONTROL COMPLICATIONS TRIAL RES GRP, 1995, DIABETES CARE, V18, P1468
  • [4] Model of Complications of NIDDM .2. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
    Eastman, RC
    Javitt, JC
    Herman, WH
    Dasbach, EJ
    CopleyMerriman, C
    Maier, W
    Dong, F
    Manninen, D
    Zbrozek, AS
    Kotsanos, J
    Garfield, SA
    Harris, M
    [J]. DIABETES CARE, 1997, 20 (05) : 735 - 744
  • [5] Diabetes in urban African/Americans. XV. Identification of barriers to provider adherence to management protocols
    El-Kebbi, IM
    Ziemer, DC
    Gallina, DL
    Dunbar, V
    Phillips, LS
    [J]. DIABETES CARE, 1999, 22 (10) : 1617 - 1620
  • [6] FOWLES J, 1990, Journal of Allergy and Clinical Immunology, V85, P195
  • [7] The cost to health plans of poor glycemic control
    Gilmer, TP
    OConnor, PJ
    Manning, WG
    Rush, WA
    [J]. DIABETES CARE, 1997, 20 (12) : 1847 - 1853
  • [8] GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436
  • [9] Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure
    Harjai, KJ
    Boulos, LM
    Smart, FW
    Turgut, T
    Krousel-Wood, MA
    Stapleton, DD
    Mehra, MR
    Murgo, JP
    Ventura, HO
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (01) : 82 - 85
  • [10] Starting insulin therapy in patients with type 2 diabetes - Effectiveness, complications, and resource utilization
    Hayward, RA
    Manning, WG
    Kaplan, SH
    Wagner, EH
    Greenfield, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (20): : 1663 - 1669